Zhang, J., Wang, L., Wang, Z., Wang, B., Cao, J., Lv, F., . . . Hu, X. (2017). Whether low-dose metronomic oral cyclophosphamide improves the response to docetaxel in first-line treatment of non-triple-negative metastatic breast cancer. Oncotarget.
Čikaški stil citiranjaZhang, Jian, Leiping Wang, Zhonghua Wang, Biyun Wang, Jun Cao, Fangfang Lv, Sheng Zhang, Zhimin Shao, i Xichun Hu. "Whether Low-dose Metronomic Oral Cyclophosphamide Improves the Response to Docetaxel in First-line Treatment of Non-triple-negative Metastatic Breast Cancer." Oncotarget 2017.
MLA način citiranjaZhang, Jian, et al. "Whether Low-dose Metronomic Oral Cyclophosphamide Improves the Response to Docetaxel in First-line Treatment of Non-triple-negative Metastatic Breast Cancer." Oncotarget 2017.